ARSENIC TRIOXIDE TARGETS BCL6 FOR DEGRADATION AND INHIBITS THE PROLIFERATION OF BCL6-DEPENDENT DIFFUSE LARGE B-CELL LYMPHOMA

被引：0
|
作者：
Tse, E. [1 ]
Yue, K. [1 ]
Chau, D. [2 ]
Kwong, Y. -L. [1 ]
机构：
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Med, Hong Kong, Hong Kong, Peoples R China
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1392
引用
收藏
页码：571 / 571
页数：1
相关论文
共 50 条
  • [41] Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations
    Sakruti, Susmita
    Bennani, Nabila
    Thota, Swapna
    Garje, Rohan
    Fawole, Adewale
    Elson, Paul
    Haddad, Abdo
    Spiro, Timothy
    Daw, Hamed
    BLOOD, 2013, 122 (21)
  • [42] Incidence and prognostic significance of BCL2, BCL6 and C-MYC rearrangements in diffuse large B-cell lymphoma.
    Kramer, MHH
    Hermans, J
    Philippo, K
    Geelen, E
    Wijburg, E
    vanKrieken, JHJM
    Schuuring, E
    Kluin, PM
    BLOOD, 1997, 90 (10) : 3916 - 3916
  • [43] BCL2 and BCL6 atypical/unbalanced gene rearrangements in diffuse large B-cell lymphoma are indicators of an aggressive clinical course
    Tourneret, Alicia
    Alame, Melissa
    Rigau, Valerie
    Bauchet, Luc
    Fabbro, Michel
    De Oliveira, Laura
    Cacheux, Valere
    Costes, Valerie
    Lacheretz-Szablewski, Vanessa
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (10) : 650 - 656
  • [44] Targeted therapy of BCL6-dependent diffuse large B-cell lymphomas by heat-shock protein 90 inhibition
    Briones, Javier
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (02) : 157 - 159
  • [45] Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
    Cardenas, Mariano G.
    Yu, Wenbo
    Beguelin, Wendy
    Teater, Matthew R.
    Geng, Huimin
    Goldstein, Rebecca L.
    Oswald, Erin
    Hatzi, Katerina
    Yang, Shao-Ning
    Cohen, Joanna
    Shaknovich, Rita
    Vanommeslaeghe, Kenno
    Cheng, Huimin
    Liang, Dongdong
    Cho, Hyo Je
    Abbott, Joshua
    Tam, Wayne
    Du, Wei
    Leonard, John P.
    Elemento, Olivier
    Cerchietti, Leandro
    Cierpicki, Tomasz
    Xue, Fengtian
    MacKerell, Alexander D., Jr.
    Melnick, Ari M.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09): : 3351 - 3362
  • [46] BCL2, BCL6 and CMYC abnormalities in 44 Turkish patients with diffuse large B-cell lymphomas
    Kahraman, D. Solakoglu
    Diniz, G.
    Koca, Y.
    Ekmekci, S.
    Ceylan, C.
    VIRCHOWS ARCHIV, 2017, 471 : S142 - S142
  • [47] BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium
    Salas, Loreta Canivilo
    Mielczarski, Bruna
    Rivero, Raquel Camara
    da Cunha Filho, Joao Sabino Lahogue
    Savaris, Ricardo Francalacci
    PLOS ONE, 2025, 20 (02):
  • [48] Design, characterization, and function of PROTACs targeting B-cell lymphoma 6 (BCL6)
    McCoull, William
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [49] Prognostic Significance of BCL6 Translocation in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.
    Shustik, Jesse
    Steidl, Christian
    Selm, Laurie
    Gascoyne, Randy D.
    BLOOD, 2008, 112 (11) : 1294 - 1295
  • [50] Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
    Iqbal, J.
    Greiner, T. C.
    Patel, K.
    Dave, B. J.
    Smith, L.
    Ji, J.
    Wright, G.
    Sanger, W. G.
    Pickering, D. L.
    Jain, S.
    Horsman, D. E.
    Shen, Y.
    Fu, K.
    Weisenburger, D. D.
    Hans, C. P.
    Campo, E.
    Gascoyne, R. D.
    Rosenwald, A.
    Jaffe, E. S.
    Delabie, J.
    Rimsza, L.
    Ott, G.
    Mueller-Hermelink, H. K.
    Connors, J. M.
    Vose, J. M.
    McKeithan, T.
    Staudt, L. M.
    Chan, W. C.
    LEUKEMIA, 2007, 21 (11) : 2332 - 2343
12345